We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of AeroClean Technologies, Inc. (“AeroClean” or the “Company”) (NASDAQ: AERC), in connection with the proposed merger of the Company with Molekule, Inc. (“Molekule”).  Under the terms of the merger agreement, AeroClean shareholders will own 50.5%, and Molekule shareholders will own 49.5% of the outstanding common equity of the combined company.

Weiss Law is investigating whether (i) AeroClean’s board of directors acted in the best interests of Company shareholders in agreeing to the proposed transaction, (ii) the per-share merger consideration adequately compensates AeroClean’s shareholders, and (iii) all information regarding the sales process and valuation of the transaction will be fully and fairly disclosed.